Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab

被引：0
|
作者：
Remolina-Bonilla, Yuly A. [1 ]
Jimenez-Franco, Brenda [1 ]
Lam, Elaine T. [2 ]
Bourlon, Maria T. [3 ]
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[2] Univ Colorado, Dept Med, Div Med Oncol, Anschutz Med Campus, Aurora, CO USA
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Hematol & Med Oncol Dept, Mexico City, DF, Mexico
来源：
ONCOLOGY-NEW YORK | 2020年 / 34卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：171 / 174
页数：4
相关论文
共 50 条
  • [31] Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis
    Washino, Satoshi
    Shirotake, Suguru
    Takeshita, Hideki
    Inoue, Masaharu
    Miura, Yuji
    Hyodo, Yoji
    Kagawa, Makoto
    Izumi, Keita
    Oyama, Masafumi
    Kawakami, Satoru
    Saito, Kazutaka
    Matsuoka, Yoh
    Taniuchi, Satsuki
    Shintani, Ayumi
    Miyagawa, Tomoaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (12) : 1651 - 1658
  • [32] Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis
    Satoshi Washino
    Suguru Shirotake
    Hideki Takeshita
    Masaharu Inoue
    Yuji Miura
    Yoji Hyodo
    Makoto Kagawa
    Keita Izumi
    Masafumi Oyama
    Satoru Kawakami
    Kazutaka Saito
    Yoh Matsuoka
    Satsuki Taniuchi
    Ayumi Shintani
    Tomoaki Miyagawa
    International Journal of Clinical Oncology, 2023, 28 : 1651 - 1658
  • [33] Genetic susceptibility to immune-related adverse events among melanoma patients treated with ipilimumab.
    Pluta, John
    Qian, Lu
    D'Andrea, Kurt
    Duan, Chunzhe
    Weathers, Benita
    Wind-Rotolo, Megan
    Kanetsky, Peter
    Nathanson, Katherine
    CANCER RESEARCH, 2021, 81 (13)
  • [34] Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
    Masuda, Ken
    Shoji, Hirokazu
    Nagashima, Kengo
    Yamamoto, Shun
    Ishikawa, Masashi
    Imazeki, Hiroshi
    Aoki, Masahiko
    Miyamoto, Takahiro
    Hirano, Hidekazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Boku, Narikazu
    BMC CANCER, 2019, 19 (01)
  • [35] Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
    Ken Masuda
    Hirokazu Shoji
    Kengo Nagashima
    Shun Yamamoto
    Masashi Ishikawa
    Hiroshi Imazeki
    Masahiko Aoki
    Takahiro Miyamoto
    Hidekazu Hirano
    Yoshitaka Honma
    Satoru Iwasa
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Narikazu Boku
    BMC Cancer, 19
  • [36] A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab
    Olson, Daniel J.
    Rajagopal, Padma
    Tjota, Melissa Y.
    Venkataraman, Girish
    Luke, Jason J.
    Gajewski, Thomas F.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [37] Ipilimumab/nivolumabRheumatological immune-related adverse events: 2 case reports
    Reactions Weekly, 2020, 1831 (1) : 171 - 171
  • [38] The predictive biomarker for immune-related adverse events (irAEs) in patients with metastatic renal cell carcinoma treated with the combination therapy of nivolumab plus ipilimumab: Musashino study-irAE
    Kizawa, R.
    Kuno, M.
    Washino, S.
    Shirotake, S.
    Izumi, K.
    Inoue, M.
    Kagawa, M.
    Takeshita, H.
    Hyodo, Y.
    Kawakami, S.
    Saito, K.
    Kageyama, Y.
    Oyama, M.
    Miyagawa, T.
    Miura, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S1488 - S1488
  • [39] Retrospective analysis of immune-related adverse events (irAE) in metastatic renal cell carcinoma (mRCC) patients treated with first-line ipilimumab and nivolumab (I plus N).
    Desai, Kunal
    Rybicki, Lisa A.
    Nizam, Amanda
    Wood, Laura S.
    Allman, Kimberly D.
    Martin, Allison
    Calabrese, Cassandra
    Gilligan, Timothy D.
    Gupta, Shilpa
    Ornstein, Moshe Chaim
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Immune-Related Adverse Events: Development of a Pilot Immune-Related Adverse Events Clinic for Expedited and Effective Patient Care
    Reid, Pankti
    Jan, Reem
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345